Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SR
Sensus Healthcare, Inc
SRTS
Volume
4.15K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
SR
SRTS
SR
Sensus Healthcare, Inc
SRTS
News
·
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders
Mkt Cap
$45.6M
Volume
4.15K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders
Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.
GlobeNewswire Inc. · Oct 9, 2025
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
Law firm investigating potential securities law violations by Sensus Healthcare after company reported significant revenue decline and stock price drop in Q2 2025.
GlobeNewswire Inc. · Oct 9, 2025
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire is investigating potential claims against AVITA Medical after the company reported a six-month backlog in unpaid provider claims for Recell procedures, which caused a 21% stock price decline.
GlobeNewswire Inc. · Oct 9, 2025
SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm
Sensus Healthcare reported Q2 2025 financial results with decreased revenue and missed earnings estimates, leading to a 35.32% stock price drop.
GlobeNewswire Inc. · Aug 31, 2025
Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
Sensus Healthcare reported Q2 2025 financial results with lower revenue and earnings, leading to a significant stock price decline and potential securities fraud investigation by Portnoy Law Firm.
GlobeNewswire Inc. · Aug 28, 2025
Sensus Healthcare, Inc. Investors: Company Investigated by the Portnoy Law Firm
Sensus Healthcare reported Q2 2025 financial results with a revenue decline of 20.7% and missed analyst earnings estimates, leading to a 35.3% stock price drop.
GlobeNewswire Inc. · Aug 21, 2025
Global Inulinase Market to Surpass USD 1,613.8 Million by 2034, Driven by 4.9% CAGR and Expanding Applications in Food, Beverages, and Dietary Supplements | Future Market Insights, Inc.
The global inulinase market is expected to grow at a CAGR of 4.9% and reach a value of over $1.6 billion by 2034, driven by increasing demand for natural and health-focused products in the food, beverage, and dietary supplement industries.
GlobeNewswire Inc. · Jan 8, 2025
Recent Price Trend in Sensus Healthcare is Your Friend, Here's Why
The article discusses the recent positive price trend in Sensus Healthcare (SRTS) and why it is a good investment opportunity. The stock has seen a steady increase in price over the past 12 weeks and 4 weeks, indicating a bullish trend. Additionally, the stock is trading at a high percentage of its 52-week range and has a favorable Zacks Rank and broker recommendation.
Benzinga · Aug 30, 2024
Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.
Zacks Investment Research · Jun 25, 2024
Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors
Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.
Zacks Investment Research · Jun 17, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
SR
SRTS
Sensus Healthcare, Inc
Buy
Sell
Market
Limit
Soon
SRTS
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any SRTS yet.
Related Tickers
Earnings